| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Oct 3, 2025 | Beam Therapeutics Inc. | CEO | Sell | 36.3 | -50,000 | -2.35% | ✓ | $1.2M |
| Apr 1, 2025 | Apr 3, 2025 | Beam Therapeutics Inc. | CEO | Sell | 38.8 | -30,663 | -2.74% | ✓ | $562.7K |
| Jan 30, 2025 | Feb 3, 2025 | Beam Therapeutics Inc. | CEO | Sell | 38.8 | -30,000 | -2.88% | ✓ | $802.5K |
| Sep 30, 2024 | Oct 2, 2024 | Beam Therapeutics Inc. | CEO | Sell | 27.5 | -60,000 | -5.45% | ✓ | $1.5M |
| Jun 27, 2024 | Jun 28, 2024 | Beam Therapeutics Inc. | CEO | Sell | 27.5 | -60,000 | -5.17% | ✓ | $1.5M |
| Apr 1, 2024 | Apr 3, 2024 | Beam Therapeutics Inc. | CEO | Sell | 42.5 | -18,102 | -1.53% | ✓ | $581.6K |
| Mar 28, 2024 | Apr 1, 2024 | Beam Therapeutics Inc. | CEO | Sell | 77.5 | +17,500 | 0.81% | ✓ | $2M |
| Jan 31, 2024 | Feb 2, 2024 | Beam Therapeutics Inc. | CEO | Sell | 32.5 | -60,000 | -4.91% | ✓ | $1.5M |
| Apr 3, 2023 | Apr 5, 2023 | Beam Therapeutics Inc. | CEO | Sell | 45.0 | -11,654 | -0.95% | ✓ | $345.3K |
| Oct 31, 2022 | Nov 2, 2022 | Beam Therapeutics Inc. | CEO | Sell | 32.5 | -50,000 | -4.13% | ✓ | $2.3M |
| Jul 28, 2022 | Jul 29, 2022 | Beam Therapeutics Inc. | CEO | Sell | 32.5 | -50,000 | -3.96% | ✓ | $3.3M |
| Apr 28, 2022 | May 2, 2022 | Beam Therapeutics Inc. | CEO | Sell | 32.5 | -50,000 | -3.81% | ✓ | $1.9M |
| Mar 31, 2022 | Apr 4, 2022 | Beam Therapeutics Inc. | CEO | Sell | 90.0 | +49,989 | 4.16% | ✗ | $370.1K |
| Nov 16, 2021 | Feb 2, 2022 | Beam Therapeutics Inc. | CEO | Sell | 27.5 | -62,000 | -5.33% | ✓ | $3.3M |
| Oct 6, 2021 | Oct 8, 2021 | Beam Therapeutics Inc. | CEO | Sell | 32.5 | -47,700 | -3.77% | ✓ | $4M |
| Aug 19, 2021 | Aug 20, 2021 | Beam Therapeutics Inc. | CEO | Sell | 23.8 | -20,000 | -8.97% | ✓ | $2M |
| Jul 7, 2021 | Jul 8, 2021 | Beam Therapeutics Inc. | CEO | Sell | 40.0 | -25,000 | -1.97% | ✓ | $2.7M |
| Apr 21, 2021 | Apr 23, 2021 | Beam Therapeutics Inc. | CEO | Sell | 40.0 | -25,000 | -1.98% | ✓ | $1.8M |
| Dec 30, 2020 | Jan 4, 2021 | Beam Therapeutics Inc. | CEO | Sell | 40.0 | -22,300 | -1.83% | ✓ | $1.9M |